MNPR - Monopar Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MNPR is currently covered by 10 analysts with an average price target of $99.77. This is a potential upside of $18.48 (22.73%) from yesterday's end of day stock price of $81.29.

Monopar Therapeutics's activity chart (see below) currently has 11 price targets and 35 ratings on display. The stock rating distribution of MNPR is 95.45% BUY and 4.55% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 83.33% with an average time for these price targets to be met of 375.14 days.

Highest price target for MNPR is $115, Lowest price target is $40, average price target is $83.

Most recent stock forecast was given by ANDREAS ARGYRIDES from OPPENHEIMER on 02-Oct-2025. First documented stock forecast 03-Feb-2020.

Currently out of the existing stock ratings of MNPR, 21 are a BUY (95.45%), 1 are a HOLD (4.55%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$115

$34.87 (43.52%)

$77

21 days ago
(02-Oct-2025)

1/2 (50%)

$17.79 (18.30%)

22

Buy

$85

$4.87 (6.08%)

$60

28 days ago
(25-Sep-2025)

4/4 (100%)

$7.56 (9.76%)

33

Buy

$95

$14.87 (18.56%)

$76

28 days ago
(25-Sep-2025)

2/2 (100%)

$17.56 (22.68%)

99

Buy

$80

$-7.82 (-8.90%)

$72

1 months 21 days ago
(02-Sep-2025)

2/2 (100%)

$43.79 (120.93%)

142

Buy

$40

$-40.13 (-50.08%)

$40

6 months 22 days ago
(01-Apr-2025)

7/7 (100%)

$6.57 (19.65%)

316

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MNPR (Monopar Therapeutics) average time for price targets to be met?

On average it took 375.14 days on average for the stock forecasts to be realized with a an average price target met ratio 83.33

Which analyst has the current highest performing score on MNPR (Monopar Therapeutics) with a proven track record?

CHRISTOPHER RAYMOND

Which analyst has the current lower performing score on MNPR (Monopar Therapeutics) with a proven track record?

ANDREAS ARGYRIDES

Which analyst has the most public recommendations on MNPR (Monopar Therapeutics)?

Christopher Raymond works at RAYMOND JAMES and has 12 price targets and 10 ratings on MNPR

Which analyst is the currently most bullish on MNPR (Monopar Therapeutics)?

Andreas Argyrides with highest potential upside - $34.87

Which analyst is the currently most reserved on MNPR (Monopar Therapeutics)?

Soumit Roy with lowest potential downside - -$70.13

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?